MedTrace Logo

Imaging and Understanding BOS in Lung Transplantation

NCT02316392 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2023-08-25

No results posted yet for this study

Summary

This study is a prospective, non-randomized, longitudinal, observational study that will recruit about 5 lung transplant patients per year for 3 years.

Conditions

  • Bronchiolitis Obliterans Syndrome

Interventions

DRUG

Hyperpolarized Helium-3 MRI

Subjects will inhale Hyperpolarized Helium-3 gas during the MRI. This gas enhances images and the data collected will be used to determine if it can be used to detect BOS earlier than current standard of care.

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Jason Woods, PhD. · Cincinnati Children's

Eligibility

Min Age
1 Year
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02316392 on ClinicalTrials.gov